Holding hands and accompanying each other_edited_edited.jpg

About Us

Founded in 2024, EG BioMed US Inc. is committed to pioneering precision medical testing with a focus on accuracy, reliability, and patient-centered care. Equipped with advanced diagnostic tools such as Real-Time PCR Systems and automated nucleic acid extractors, the company ensures the highest quality of testing. With a professional team and personalized service, EG BioMed US aims to drive innovation in precision medical diagnostics and promote health awareness through community outreach.

Corporate Overview

EG BioMed US Inc.

Founded in 2024, EG BioMed US Inc. aims to pioneer precision medical testing, emphasizing accuracy, reliability, and a patient-centered approach while maintaining the highest diagnostic standards.

Core Technology

Real-Time PCR Systems enable rapid and accurate DNA amplification and quantification, enhancing the detection of infections and genetic disorders in diagnostics and research, thus improving clinical decision-making.

Testing Services

The Factor V Leiden Mutation Analysis uses real-time PCR to detect the wild type F5 gene and the c.1691G>A (F5 Leiden) variant, aiding in the diagnosis of thrombophilia.